Allianz Asset Management GmbH - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 109 filers reported holding AXSOME THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$726,000
+44.6%
10,760
+74.6%
0.00%
Q4 2020$502,000
-36.0%
6,162
-44.0%
0.00%
-100.0%
Q3 2020$784,000
-73.8%
10,999
-78.3%
0.00%
-75.0%
Q1 2020$2,989,000
-5.4%
50,794
+66.3%
0.00%
+33.3%
Q4 2019$3,158,000
+400.5%
30,550
-2.1%
0.00%
+200.0%
Q3 2019$631,000
-63.6%
31,191
-53.7%
0.00%
-50.0%
Q2 2019$1,735,000
+146.4%
67,373
-46.4%
0.00%
+100.0%
Q4 2017$704,000
+1.0%
125,6700.0%0.00%0.0%
Q3 2017$697,000
-3.6%
125,6700.0%0.00%0.0%
Q2 2017$723,000
+44.6%
125,670
-2.0%
0.00%
Q1 2017$500,000
-32.7%
128,200
+16.5%
0.00%
-100.0%
Q4 2016$743,000
-12.3%
110,0900.0%0.00%0.0%
Q3 2016$847,000
-5.8%
110,090
-7.7%
0.00%0.0%
Q2 2016$899,000
-12.3%
119,2400.0%0.00%0.0%
Q1 2016$1,025,000
-4.9%
119,240
+1.8%
0.00%0.0%
Q4 2015$1,078,000117,1650.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,132,645$37,332,00032.86%
MORGAN JESS S & CO INC 113,430$3,739,0002.47%
Fairmount Funds Management LLC 187,598$6,183,0002.25%
IRIDIAN ASSET MANAGEMENT LLC/CT 1,423,653$46,924,0001.43%
WMS Partners, LLC 250,000$8,240,0001.21%
Beck Bode, LLC 102,127$3,366,0000.94%
RTW INVESTMENTS, LP 1,616,497$53,280,0000.80%
MPM BioImpact LLC 110,155$3,631,0000.56%
Endurant Capital Management LP 52,048$1,716,0000.39%
Bellevue Group AG 752,945$24,817,0000.25%
View complete list of AXSOME THERAPEUTICS INC shareholders